Start › Rak płuc › Kentucky › Lexington
Badania kliniczne dla Rak płuc w mieście Lexington, KY
18 badań dla Rak płuc szuka uczestników w ośrodkach w mieście Lexington i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekrutacjaFaza 3
- Baptist Health Lexington, Lexington
- Baptist Health Hamburg, Lexington
- University of Kentucky/Markey Cancer Center, Lexington
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
RekrutacjaFaza 2
- University of Kentucky Chandler Medical Center ( Site 0019), Lexington
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekrutacjaBadanie obserwacyjneZapraszamy zdrowych ochotników
- CommonSpirit Saint Joseph Hospital - Lexington, Lexington
- Saint Joseph Radiation Oncology Resource Center, Lexington
- CommonSpirit Saint Joseph Medical Center - East Lexington, Lexington
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
RekrutacjaFaza 3
- University of Kentucky/Markey Cancer Center, Lexington
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
RekrutacjaFaza 2/3
- Baptist Health Lexington, Lexington
- University of Kentucky Chandler Medical Center, Lexington
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
RekrutacjaFaza 2/3
- Baptist Health Lexington, Lexington
- University of Kentucky Chandler Medical Center (UKCMC) - Markey Cancer Center (Lucille P. Markey Cancer Center), Lexington
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
RekrutacjaFaza 1/2
- University of Kentucky/Markey Cancer Center, Lexington
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekrutacjaFaza 3
- CHI Saint Joseph Cancer Center - East, Lexington
- University of Kentucky Chandler Medical Center, Lexington
A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)
RekrutacjaFaza 2
- University of Kentucky ( Site 0019), Lexington
EXoPERT EMERALD Clinical Study
RekrutacjaBadanie obserwacyjneZapraszamy zdrowych ochotników
- Lexington VA Healthcare System, Lexington
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekrutacjaFaza 2
- University of Kentucky/Markey Cancer Center, Lexington
Pathways, a Hope Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life During Advanced Lung Cancer Treatment
Rekrutacja
- University of Kentucky, Lexington
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekrutacjaFaza 2
- University of Kentucky/Markey Cancer Center, Lexington
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekrutacjaFaza 2/3
- University of Kentucky/Markey Cancer Center, Lexington
Precision Lung Cancer Survivorship Care Intervention
Rekrutacja
- Markey Cancer Center, Lexington
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RekrutacjaFaza 1
- University of Kentucky Markey Cancer Center, Lexington
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RekrutacjaBadanie obserwacyjneZapraszamy zdrowych ochotników
- Baptist Lexington, Lexington
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
RekrutacjaBadanie obserwacyjne
- Lexington VA Health Care System, Lexington
Badania dla Rak płuc w innych miastach
- Houston, TX78 badań
- Boston, MA62 badań
- New York City, NY60 badań
- Los Angeles, CA45 badań
- Washington, DC41 badań
- Arlington, VA41 badań
- Chicago, IL41 badań
- Nashville, TN40 badań
- Baltimore, MD40 badań
- St. Louis, MO39 badań
- Columbus, OH37 badań
- Philadelphia, PA36 badań
Inne badania w mieście Lexington
- Niedrobnokomórkowy rak płuca23 badań
- Rak jajnika16 badań
- Nowotwory (wszystkie typy)14 badań
- Rak prostaty14 badań
- Rak piersi14 badań
- Nowotwór przerzutowy11 badań
- Niewydolność serca11 badań
- Rak jelita grubego i odbytnicy11 badań
- Otyłość10 badań
- Ostra białaczka szpikowa10 badań
- Czerniak10 badań
- Rak trzustki9 badań
Źródło: ClinicalTrials.gov, dane pobrane 5 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.